Name | Sector | Analyst Name | Analyst Job Title | Star Rating | Date | |
---|---|---|---|---|---|---|
UCB SA | Healthcare | Rachel Elfman | Equity Analyst | 02/12/2024 | ||
AbbVie Inc | Healthcare | Karen Andersen | Strategist | 02/12/2024 | ||
Amgen Inc | Healthcare | Karen Andersen | Strategist | 02/12/2024 | ||
AstraZeneca PLC | Healthcare | Karen Andersen | Strategist | 02/12/2024 | ||
AstraZeneca PLC ADR | Healthcare | Karen Andersen | Strategist | 02/12/2024 | ||
Biogen Inc | Healthcare | Karen Andersen | Strategist | 02/12/2024 | ||
BioNTech SE ADR | Healthcare | Karen Andersen | Strategist | 02/12/2024 | ||
Bristol-Myers Squibb Co | Healthcare | Karen Andersen | Strategist | 02/12/2024 | ||
Eli Lilly and Co | Healthcare | Karen Andersen | Strategist | 02/12/2024 | ||
Gilead Sciences Inc | Healthcare | Karen Andersen | Strategist | 02/12/2024 | ||
GSK PLC | Healthcare | Karen Andersen | Strategist | 02/12/2024 | ||
GSK PLC ADR | Healthcare | Karen Andersen | Strategist | 02/12/2024 | ||
Johnson & Johnson | Healthcare | Karen Andersen | Strategist | 02/12/2024 | ||
Merck & Co Inc | Healthcare | Karen Andersen | Strategist | 02/12/2024 | ||
Moderna Inc | Healthcare | Karen Andersen | Strategist | 02/12/2024 | ||
Novartis AG ADR | Healthcare | Karen Andersen | Strategist | 02/12/2024 | ||
Novartis AG Registered Shares | Healthcare | Karen Andersen | Strategist | 02/12/2024 | ||
Novo Nordisk AS ADR | Healthcare | Karen Andersen | Strategist | 02/12/2024 | ||
Novo Nordisk AS Class B | Healthcare | Karen Andersen | Strategist | 02/12/2024 | ||
Pfizer Inc | Healthcare | Karen Andersen | Strategist | 02/12/2024 |